How do we Consider Multiple Myeloma. One Institute, 20 Years of Experience - Abstract
Multiple myeloma, a malignant proliferation of plasma cells, is still incurable. This disease, 1% of all human malignancies, is responsible for almost 2 % of the whole cancer related mortality. In this review the authors summarize their 20 years experience in the field of myeloma research aiming to find factors predisposing to myeloma and looking for prognostic markers. In the last two years (2012 and 2013) this team diagnosed and treated 259 myeloma patients: 119 in 2012 and 140 in 2013.